Physiomics Share Discussion Threads

[mister md] 30/5/2018 14:13

"Really odd the price is down in the 4's."

Perhaps this has something to do with it :)

Physiomics ... has completed a placing, conditional only on Admission, to raise GBP525,000.00 (gross) from the issue of 13,125,000 new ordinary shares of 0.4p each ("Ordinary Shares") at a price of 4.0p per share... and dealing is expected to commence on 31(st) May 2018

[the stigologist] 30/5/2018 14:01

Looks like Innovate UK are back out funding Companies as part of Biomedical Catalyst fund.

If PYC secure say £0.525m from Innovate UK (having got £0.525m from 'the Market') it would mean £1.05m of funding for the issue of 13m shares

i.e. an equivalent price of 8p per share

If PYC secure say £0.2625m that would mean a total of £07875m for the issue of 13m shares

i.e. an equivalent price of 6p per share

Suffice to say I expect PYC management to be proven to have done shareholders a good deal by raising this GROWTH CAPITAL

[the stigologist] 30/5/2018 13:18

By the way those of you not on Twitter I've posted there re the March 2018 option grant at 5.35p

Really odd the price is down in the 4's.

Almost like AIM mug punters are clueless or something.

[davevt] 30/5/2018 12:59

Pyc doesn't do anything close to what your 'comparitors' do. That's why they are 850 million and pyc is 4 million.

[the stigologist] 30/5/2018 12:56

IF the UK investor market does not recognise the value potential of £4m PYC then I expect their peers will and there will be Corporate/Strategic action here

Comparitors
B2B In-Silico Clinical Trials / BioSimulation / Modelling and Simulation market
Certara $850m
Simulations Plus $300m

B2C Personalised Medicine market
DeepMind $500m+ (acquired by Google)
GRAIL inc $1000m+ funding from Big Pharma, Bill Gates, Jeff Bezos

[davevt] 30/5/2018 12:05

But tell us more about '100p' and 'non dilutive funding'...

[412069] 30/5/2018 12:04

PYC charts identical to VAL, which will spike first agains is the trick of this aim game.

[davevt] 30/5/2018 12:03

It's gone more his direction than yours though hasn't it. And what will this share do on new news? Well seeing as the 30p was a brief spike with no volume, and it settled to 12p and dropped soon after, and that was with no one already in position, completely out of the blue news, being ramped and 'made up fantasy' claims...'cure for cancer' etc...then you may see 8p on a big contract, seeing as everyone and it's dog knows about pyc now, loads more people in position ready to sell etc.

[the stigologist] 30/5/2018 11:28

On October 2nd 2017 Physiomics told us they expected to complete a deal with a Big Pharma

On November 28th 2017 they announced that deal.

It was 'old news' but the stock still went up 3100% within 48 hours.

What will 'new news' do to this stock ?

When we know it's comparitors are valued at 100x ! PYC

Worth repeating even their clueless brokers Hybridan have never mentioned likes of Certara, DeepMind, GRAIL inc so it will come as a total surprise to 'the market'

[the stigologist] 30/5/2018 11:08

Placing insiders now buying in the market.

There. Is. News. Coming.

[davevt] 30/5/2018 08:23

No I'm not a holder, I just trade in and out. I just know rampers ruin a share, and face palm every time they still ramp even when the price is going down and down.

[pwhite73] 30/5/2018 07:21

I'm not sure we are both on the same side of the fence. davetv sounds more like a disgruntled holder more than anything else but I could be wrong. I am an ex-holder that has suffered the same fate as all you existing holders. I held on and on and on in the belief that someday the pharma world would wake up the uniqueness and brilliance of this company and its main product Virtual Tumour.

It took years and years to realise that they have no intention of going anywhere except to a comfortable retirement for the most senior of executives and a steady modest annual income for those with a few years left to go. Nothing has changed since 2004.

[hms_trader] 29/5/2018 22:39

Again, the number of trades in preceding days has nothing to do with the likelihood of investors taking up a placing at 1p.Oh and ofcourse you would say Dave is right what with you both being in the same side Of The fence with this share.

[pwhite73] 29/5/2018 22:24

hms_trader

Don't just yak for the sake of it. In the case of PYC the facts are out there and the directors do not lie unlike most AIM companies.

On the day they announced the Merck deal Tuesday 28/11/2017 there were 1463 trades that's right one thousand four hundred and sixty three trades. These are the numbers for the previous days.

27/11/2017 - 2 trades all day
24/11/2017 - 2 trades all day
23/11/2017 - 2 trades all day
22/11/2017 - 3 trades all day
21/11/2017 - 6 trades all day
20/11/2017 - 0 trades all day and it wasn't even a weekend.

davevt is correct. PYC could not have got away with a placing on those sorts of numbers.I have followed this company longer and harder than all of you put together and know more than all of you put together.

[hms_trader] 29/5/2018 19:37

Pwhite nothing you have said proves that investors would not be interested in buying sub 1p shares post consolidation, which is what Daves original point was

[pwhite73] 29/5/2018 18:49

hms_trader - "That logic does not stand. Too many shares in issue does not have a bearing in buyers being attracted.."

RNS 23/11/2016 - "The Board believes that the Share Consolidation will result in a more appropriate number of shares in issue for a company of Physiomics' size in the UK market. The Share Consolidation may also help to make the Company's shares more attractive to investors and may result in a narrowing of the bid/offer spread, thereby improving liquidity"

The directors of PYC disagree with you on that point and so do I because of the type of company PYC is and the improbablity of any company transforming news. They could not have got a away with a placing in 2017 at a discount to 1p after a 100 - 1 consolidation in late 2016.

Anyway moving on there the shares are now at 4.30p and they are going lower returning to 2p.

[davevt] 29/5/2018 17:07

Because that would mean he would have to prove if he own any shares at all.

[spacedust] 29/5/2018 16:43

What's the deal with not going over 3%. Why Not?

I Also have 2.99%
Anyone else have 2.99% just below rns

[the stigologist] 29/5/2018 14:51

"Following the Company's success in signing a deal with Merck KGaA in November 2017 (expected income of EUR500k in calendar 2018), the signing of three further clients in the first four months of 2018 (total expected income of GBP153k in calendar 2018) and the award of a second Innovate UK grant in the field of personalised cancer treatment (expected income GBP68k in calendar 2018) ...

the Company has had significant interest from potential new clients.

In order to service this level of actual and potential new business the Company is raising funds through the Placing to enable it to carry out associated activities including :-

investing in expanding its in-house team, [growing the team +ve ]

improving its marketing reach, [still wanting to grow despite +200% revenue increase]

match funding for future grant projects, [Wall of Money coming from Govt]

and updating its IT infrastructure [if you mix with Google/GRAIL etc you need computers/servers/databases to do 'big data'/cloud/AI processing]

as well as for general working capital purposes. [standard boilerplate catchall]

[the stigologist] 29/5/2018 14:50

One of the other good things about the Placing is that it allows those who were just below 3% to buy more without now going over the reporting threshold.

2m+ now

[hms_trader] 29/5/2018 14:06

That logic does not stand. Too many shares in issue does not have a bearing in buyers being attracted, rather it's the price and the valuation that dictate levels of interest

[pwhite73] 29/5/2018 13:53

The reason Dave gave was the exact reason no new equity was issued in 2017. In the AGM Dec 2016 the company did not state the maximum shares that could be issued in 2017 so they would have had to of called an EGM to issue any amount of shares. In Sept 2016 the company had done 100-1 consolidation on the grounds there were too many shares in issue. So it would have been difficult to get buyers for shares at sub 1p.I have said before and I'll say it again if it wasn't for the November 2017 frenzy PYC would have delisted.

[davevt] 29/5/2018 11:48

Yes, quit while your behind.